Pharmacy alerts
-
Finasteride and Dutasteride – updated safety warnings
The MHRA has reviewed evidence for the risk of psychiatric side effects and sexual dysfunction.
-
Milpharm Limited, loperamide hydrochloride 2 mg orodispersible tablets defect notification
Class 4 medicines defect notification: The MHRA has issued a Class 4 defect notification for loperamide hydrochloride 2 mg orodispersible tablets
-
Nasal decongestant sprays and drops containing xylometazoline hydrochloride/ oxymetazoline hydrochloride
Drug Safety Update: The MHRA has published a drug safety update on nasal decongestant sprays and drops containing xylometazoline hydrochloride/oxymetazoline hydrochloride.
-
Amarox Limited, Sertraline 100mg film-coated tablets recall
Class 2 medicines recall: The MHRA has published a Class 2 medicines recall for Sertraline 100mg film-coated tablets.
-
Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets recall
Class 3 medicines recall: The MHRA has issued a Class 3 medicines recall for Napralief 250mg gastro-resistant tablets.
-
Doncaster Pharma Limited, Hiprex 1g tablets medicines defect
Class 4 medicines defect notification: The MHRA has published a class 4 medicines defect notification for Hiprex 1g tablets.